Long-term non-invasive ventilation for stable chronic hypercapnic COPD
Introduction: Long-term non-invasive ventilation (LTNIV) for the stable hypercapnic chronic obstructive pulmonary disease (COPD)-patients have been a subject of much debate in the last two decades. The aim of this study was to compile the current knowledge on LTNIV in order to evaluate the effects o...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-01-01
|
| Series: | European Clinical Respiratory Journal |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/20018525.2019.1644893 |
| _version_ | 1818922907067219968 |
|---|---|
| author | Eline K. Gantzhorn Thomas Skovhus Prior Ole Hilberg |
| author_facet | Eline K. Gantzhorn Thomas Skovhus Prior Ole Hilberg |
| author_sort | Eline K. Gantzhorn |
| collection | DOAJ |
| description | Introduction: Long-term non-invasive ventilation (LTNIV) for the stable hypercapnic chronic obstructive pulmonary disease (COPD)-patients have been a subject of much debate in the last two decades. The aim of this study was to compile the current knowledge on LTNIV in order to evaluate the effects on mortality and hypercapnia. Methods: Literature search in Pubmed, Ovid, and Embase for RCTs in Humans from January 2000 through January 2019 in written English. Results: Six studies with a total of 861 patients were included. LTNIV in stable hypercapnic COPD patients significantly reduced PaCO2 but only one study found significant reduction in mortality. Conclusion: Our meta-analyses demonstrate that LTNIV significantly reduced PaCO2 in stable patients with chronic hypercapnic respiratory failure compared to standard care alone, and subgroup analyses on studies with a predefined plan for ventilation, showed a considerable trend towards significant reduction in mortality. The take home messages on LTNIV in stable hypercapnic COPD are: It is essential that the patients have stable chronic hypercapnia. The degree of stability can best be assessed after a minimum of 2 weeks following an acute hypercapnic respiratory failure (AHRF). It is important to ventilate the patient with the goal to reduce PaCO2 by at least 20% or below 6.5 kPa. |
| first_indexed | 2024-12-20T02:00:59Z |
| format | Article |
| id | doaj.art-ff7601c1dbf34e4384fb4c718729ffd3 |
| institution | Directory Open Access Journal |
| issn | 2001-8525 |
| language | English |
| last_indexed | 2024-12-20T02:00:59Z |
| publishDate | 2019-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | European Clinical Respiratory Journal |
| spelling | doaj.art-ff7601c1dbf34e4384fb4c718729ffd32022-12-21T19:57:19ZengTaylor & Francis GroupEuropean Clinical Respiratory Journal2001-85252019-01-016110.1080/20018525.2019.16448931644893Long-term non-invasive ventilation for stable chronic hypercapnic COPDEline K. Gantzhorn0Thomas Skovhus Prior1Ole Hilberg2Lillebaelt Hospital, University Hospital of Southern DenmarkAarhus University Hospital, Aarhus DenmarkLillebaelt Hospital, University Hospital of Southern DenmarkIntroduction: Long-term non-invasive ventilation (LTNIV) for the stable hypercapnic chronic obstructive pulmonary disease (COPD)-patients have been a subject of much debate in the last two decades. The aim of this study was to compile the current knowledge on LTNIV in order to evaluate the effects on mortality and hypercapnia. Methods: Literature search in Pubmed, Ovid, and Embase for RCTs in Humans from January 2000 through January 2019 in written English. Results: Six studies with a total of 861 patients were included. LTNIV in stable hypercapnic COPD patients significantly reduced PaCO2 but only one study found significant reduction in mortality. Conclusion: Our meta-analyses demonstrate that LTNIV significantly reduced PaCO2 in stable patients with chronic hypercapnic respiratory failure compared to standard care alone, and subgroup analyses on studies with a predefined plan for ventilation, showed a considerable trend towards significant reduction in mortality. The take home messages on LTNIV in stable hypercapnic COPD are: It is essential that the patients have stable chronic hypercapnia. The degree of stability can best be assessed after a minimum of 2 weeks following an acute hypercapnic respiratory failure (AHRF). It is important to ventilate the patient with the goal to reduce PaCO2 by at least 20% or below 6.5 kPa.http://dx.doi.org/10.1080/20018525.2019.1644893copdnon-invasive ventilationchronic hypercapniahome mechanical ventilationnivchronic obstructive pulmonary disease |
| spellingShingle | Eline K. Gantzhorn Thomas Skovhus Prior Ole Hilberg Long-term non-invasive ventilation for stable chronic hypercapnic COPD European Clinical Respiratory Journal copd non-invasive ventilation chronic hypercapnia home mechanical ventilation niv chronic obstructive pulmonary disease |
| title | Long-term non-invasive ventilation for stable chronic hypercapnic COPD |
| title_full | Long-term non-invasive ventilation for stable chronic hypercapnic COPD |
| title_fullStr | Long-term non-invasive ventilation for stable chronic hypercapnic COPD |
| title_full_unstemmed | Long-term non-invasive ventilation for stable chronic hypercapnic COPD |
| title_short | Long-term non-invasive ventilation for stable chronic hypercapnic COPD |
| title_sort | long term non invasive ventilation for stable chronic hypercapnic copd |
| topic | copd non-invasive ventilation chronic hypercapnia home mechanical ventilation niv chronic obstructive pulmonary disease |
| url | http://dx.doi.org/10.1080/20018525.2019.1644893 |
| work_keys_str_mv | AT elinekgantzhorn longtermnoninvasiveventilationforstablechronichypercapniccopd AT thomasskovhusprior longtermnoninvasiveventilationforstablechronichypercapniccopd AT olehilberg longtermnoninvasiveventilationforstablechronichypercapniccopd |